Vaccination during pregnancy is a crucial strategy to safeguard both maternal and fetal health by providing protection against infectious diseases. Certain vaccines are specifically recommended for pregnant women to prevent complications for both the mother and the unborn child. The influenza (flu) vaccine is routinely recommended during pregnancy to reduce the risk of severe illness and complications associated with flu infections. Additionally, the tetanus, diphtheria, and pertussis (Tdap) vaccine are often administered during each pregnancy to provide passive immunity to the newborn against pertussis. Vaccinating pregnant women not only protects them but also transfers some immunity to the infant, offering early protection during the vulnerable first months of life. These vaccines are considered safe during pregnancy, and healthcare providers play a vital role in educating pregnant women about the benefits of vaccination. Research continues to explore additional vaccines that can be safely administered during pregnancy to enhance maternal and fetal immunity. By prioritizing vaccination for pregnant women, public health efforts aim to reduce the risk of infectious diseases for both mother and child.
Submit your abstract Today
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Prophylactic and Molecular Approaches for Mitigating Human Influenza A Viruses: i. Evaluating influenza Vaccine Effectiveness in the Older population ii. Down-regulation of influenza virus genes with novel siRNA-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations
Ayesha Zahid, Griffith University, Australia
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan